CVS Health Payor Solutions
Payor Solutions
Main menu
Biosimilars
About
Our Story
Who We Serve
Integrated Assets
Insights
All Insights
Care Management
Cost Management
Drug Pipeline
GLP-1s
Government Programs & Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Contributors
Programs & Services
Overview
Cost Management
Formulary Management
Network Strategies
Hyperinflation
Gene Therapy Solutions
Member Affordability
Specialty Management
Specialty Cost Management
Medical Benefit Solutions
Transform Oncology Care
Patient Care
Radiation Oncology
Care Management
Member Engagement
Onboarding
Benefit Plan Changes
Health Plan Client Engagement
Shortcuts
Contact Us
Resources
Videos
News
Webinars
Events
Other Sites
Client Care Access
CVS Health
CVS Caremark
CVS Specialty
CVS Pharmacy
CVS MinuteClinic
Search form
Search
Insights provides context and perspective about key pharmacy trends and issues
Format
All Formats
Briefing
Commentary
Feature
Infographic
Specialty Report
Video
White Paper
Insights Topic (field_insights_topic)
Care Management
Cost Management
Drug Pipeline
Government Programs and Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Sort by
Most Recent
Most Popular
Insights Topic (field_insights_topic)
- Any -
Care Management
Cost Management
Drug Pipeline
Government Programs and Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Drug Pipeline
Getting personal with mRNA cancer vaccines
Getting personal with mRNA vaccines for cancer
More
Briefing
Cost Management
Keeping Medications Affordable for Members
Keeping medications affordable for members
More
Briefing
Drug Pipeline
Protecting Infants and Young Children from RSV
Protecting Infants and Young Children from RSV
More
Briefing
Insights
offers context and perspective about key pharmacy and health care topics.
Subscribe
Care Management
The Rise of GLP-1s to Improve Metabolic Health
New CVS Caremark white paper describes the reasons for the rapid increase in utilization of GLP-1 drugs to treat diabetes and obesity.
More
Briefing
Cost Management
Next in Gene Therapy: 2024 Roundup
An update on the gene therapy pipeline
More
Briefing
Health Equity
Understanding Disparities in Alzheimer’s Disease and Dementia
Understanding and addressing root causes of disparities in Alzheimer’s and dementia can help advance health equity and improve health outcomes
More
Briefing
Care Management
Metabolism Matters: Building a Blueprint for Improved Outcomes
Diabetes and obesity result from poor metabolic health and are associated with more than 200 chronic diseases. Focusing on metabolic health can help to improve health status overall.
More
Briefing
Innovation
What You Need to Know About PBMs
CVS Health PBM
More
Briefing
Cost Management
Maximize your savings through the power of integration
Integration saves money for you and your members, delivers administrative simplicity and enhances opportunities for member support.
More
Briefing
Cost Management
2024 CVS Caremark Formulary Updates
...
More
Briefing
Drug Pipeline
Drugs to Watch: Anticipated Q4 2023 Launches
The drug pipeline continues to flow. See what new therapies are expected to launch in the fourth quarter of 2023.
More
Briefing
Drug Pipeline
Getting personal with mRNA cancer vaccines
Getting personal with mRNA vaccines for cancer
More
Briefing
Cost Management
Gene Therapy for Sickle Cell Disease
Gene therapy to treat sickle cell disease could soon be a reality
More
Briefing
Load more